Skip to content

Naftifine

Allylamine Antifungal — DERMATOLOGICALS

Also known as: naftifin, naftifine HCl, naftifine hydrochloride, naftifungin

OfpFDA approvedATC D01AE22

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Naftifine is an ofp drug in the Allylamine Antifungal class catalogued in DrugCentral. It was first approved by the FDA in 1988. DrugCentral lists 7 molecular targets, including crtN, ERG2 and ERG1. Recorded indications include Tinea corporis, Tinea cruris and Tinea pedis.

  • Approval status: ofp (first approved 1988 by the FDA).
  • Drug class: Allylamine Antifungal.
  • Molecular targets: crtN, ERG2, ERG1 and SIGMAR1 (7 listed in DrugCentral).
  • Indications: Tinea corporis, Tinea cruris and Tinea pedis.
  • ATC code: D01AE22 (Other antifungals for topical use).
  • Molecular formula: C21H21N; molecular weight 287.41 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

  • Tinea corporis
  • Tinea cruris
  • Tinea pedis

Off-label uses (1)

  • Pityriasis versicolor

Mechanism & targets

Established pharmacologic classAllylamine Antifungal

Molecular targets (7)

TargetGeneActionActivity
Dehydrosqualene desaturasecrtNunknownIC50 6.53
C-8 sterol isomeraseERG2unknownKi 6.51
Squalene monooxygenaseERG1unknownIC50 6.50
Sigma non-opioid intracellular receptor 1SIGMAR1unknownKi 6.06
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomeraseEBPunknownKi 5.82
Squalene epoxidase—inhibitor—
Squalene monooxygenaseSQLEunknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1988-02-29FDA—MERZ PHARMS

ATC classification

ATC codeTherapeutic hierarchy
D01AE22DERMATOLOGICALS › ANTIFUNGALS FOR DERMATOLOGICAL USE › ANTIFUNGALS FOR TOPICAL USE › Other antifungals for topical use

Chemical structure

Molecular formulaC21H21N
Molecular weight287.41 g/mol
CAS number65472-88-0
InChIKeyOZGNYLLQHRPOBR-DHZHZOJOSA-N
PubChem CID47641
CN(C\C=C\C1=CC=CC=C1)CC1=CC=CC2=CC=CC=C12

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Naftifine used for?

DrugCentral lists the following indications for Naftifine: Tinea corporis, Tinea cruris and Tinea pedis.

How does Naftifine work?

Its molecular targets in DrugCentral include crtN, ERG2, ERG1 and SIGMAR1.

When was Naftifine first approved?

Naftifine was first approved by the FDA in 1988.

What drug class does Naftifine belong to?

Naftifine is in the Allylamine Antifungal class.

What is the chemical formula of Naftifine?

Naftifine has the molecular formula C21H21N and a molecular weight of 287.41 g/mol.

Browse: all drugs starting with N · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1988-02-29
AgencyFDA
Targets7
Indications3
FormulaC21H21N
DrugCentral ID1872
Interactive profile